A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
Titel:
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
Auteur:
Grundman, Michael Morgan, Roger Lickliter, Jason D. Schneider, Lon S. DeKosky, Steven Izzo, Nicholas J. Guttendorf, Robert Higgin, Michelle Pribyl, Julie Mozzoni, Kelsie Safferstein, Hank Catalano, Susan M.
Verschenen in:
Alzheimer's & dementia. Translational research & clinical interventions